Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries

Last updated: September 15, 2019
Sponsor: RWJ Barnabas Health at Jersey City Medical Center
Overall Status: Active - Recruiting

Phase

2

Condition

Endometriosis

Gynecological Infections

Soft Tissue Infections

Treatment

N/A

Clinical Study ID

NCT03960970
Prophylaxis Trial
  • Ages > 18
  • Female

Study Summary

Cesarean deliveries are the most common surgical procedure performed in the United States. A significant decrease in cesarean delivery associated maternal morbidity has been achieved with preoperative prophylactic single-dose cephalosporin, widely used before skin incision. Also, on laboring patients and/or with rupture of membranes, several studies suggest that adding azithromycin to standard cephalosporin prophylaxis is cost-effective and reduces overall rates of endometritis, wound infection, readmission, use of antibiotics and serious maternal events. Azithromycin has effective coverage against Ureaplasma, associated with increased rates of endometritis. Although two-drug regimen has been suggested for laboring and/or patients that undergo cesarean delivery, no studies have investigated the potential benefits of two-drug regimen in non-laboring patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Pregnant women 18 years or older

  • Women undergoing primary or repeat cesarean delivery

  • Singleton gestation

  • Gestational age greater than 34 weeks

  • Pregnant patients undergoing scheduled cesarean delivery

  • Intact membranes

  • Non-laboring

  • Signed informed consent

Exclusion

Exclusion Criteria:

  • Maternal age < 18 years

  • Multi-fetal gestation

  • Known allergy to cephalosporin or azithromycin

  • Patient unwilling or unable to provide consent

  • Diagnosis of rupture of membranes

  • Intraamniotic infection, or any other active bacterial infection (e.g. pyelonephritis,pneumonia, abscess) at time of randomization.

  • Immunocompromising medical conditions: HIV positive with CD4 count below 200, chronicsteroid use, current diagnosis of cancer and/or chemotherapy age use

  • Emergent cesarean precluding consent or availability of study medication

  • Need for hysterectomy at time of delivery

  • Use of antibiotic in the 72 hours prior to admission, with exception to patientreceiving antibiotics for GBS

  • Inability to contact patient on postpartum period.

Study Design

Total Participants: 800
Study Start date:
September 15, 2019
Estimated Completion Date:
November 30, 2020

Study Description

Cesarean deliveries are the most common surgical procedure performed in the United States, and scheduled cesarean deliveries account for at least 40% of all cesarean deliveries every year. A significant decrease in cesarean delivery associated maternal morbidity has been achieved with preoperative prophylactic single-dose cephalosporin given within 60 minutes of skin incision. Also, on laboring patients and/or with rupture of membranes, several studies suggest that adding azithromycin to standard cephalosporin prophylaxis is not only cost-effective but reduces overall rates of endometritis and wound infection. Azithromycin provides effective coverage against Ureaplasma, commonly associated with increased rates of endometritis. Although two-drug regimen has been suggested for laboring and/or patients that undergo cesarean delivery, no studies have investigated the potential benefits of two-drug regimen in non-laboring patients. No increase in neonatal morbidity was noted with adjunctive azithromycin prophylaxis, including adverse events.

Connect with a study center

  • Jersey City Medical Center

    Jersey City, New Jersey 07302
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.